方法采用减低剂量的Bu/Cy+ATG方案,进行异基因造血干细胞移植治疗18例恶性血液病,预处理方案是:马利兰(BU)4 mg/(kg·d)×3,环磷酰胺(CY)60mg/(kg·d)×2,司莫司汀(Me-CCNU)450mg/(m2·d)×1,抗胸腺细胞球蛋白(ATG)3mg/(kg·d)×2。采用环孢素A+霉酚酸酯(MMF)+短程MTX预防GVHD。结果18例患者...
采用减低剂量的Bu/Cy+ATG方案,进行异基因造血干细胞移植治疗18例恶性 血液病,预处理方案是:马利兰(BU) 4mg/(kg?d)×3,环磷酰胺(CY)60mg/(kg?d)×2,司莫司汀 (Me—CCNU)450mg/(m?d)×1,抗胸腺细胞球蛋白 (ATG)3mg/(kg?d)×2.采用环孢素A+霉酚酸酯(MMF)+短程MTX预防GVHD.结 ...
(CP),移植前格列卫疗程中位数为25(7~60)d,供受者HLA完全相合,亲缘相关供者9例,非亲缘供者5例,预处理方案为TBI+Cy+VP16或Bu/Cy±ATG,GVHD预防按常规方案... 孟凡义,孙竞,刘启发,... - 《白血病·淋巴瘤》 被引量: 0发表: 2006年 异基因造血干细胞移植治疗恶性组织细胞病 目的 探讨异基因造血干细胞...
ATG 2 例 ,使用费城尤斯 34 例 ,使用 ALG 1例。 五、对症支持治疗及并发症的预防 所有患者移植前人住无菌层 流病房 ,预处理过 程 中水化 和碱化尿液 预防出血性膀胱炎 。静脉注 射肝素钠预 防肝静脉闭塞综合征 ,一9- +35 d应用肝 素钠80 Iu ·kg～·d一。预防感染包括 :静脉注射头孢 ...
Ara-C_BU_CY_ATG 主站 番剧 游戏中心 直播 会员购 漫画 赛事 下载客户端 登录 开通大会员 大会员 消息 动态 收藏 历史记录 创作中心 投稿 关注发消息 主页动态投稿0合集和列表0 关注数 719 粉丝数 2 TA的视频 TA的专栏 个人资料 UID135588 登录后你可以:...
a对传统Bu+Cy+ATG预处理方案进行改良,研究是否可以减少预处理毒性、增加清髓效果、免疫抑制效果。 Carries on the improvement to the traditional Bu+Cy+ATG pretreatment plan, studies whether can reduce the pretreatment toxicity, increase the clear marrow effect, the immunosuppression effect.[translate]...
In multivariate analysis, age, cytogenetic risk groups, use of ATG and interval from diagnosis to alloSCT were not significant prognostic factors for survival. In all, these results suggest that in AML patients in Rel 1 undergoing myeloablative alloSCT, Bu/Cy and TBI/Cy conditioning regimens can...
In multivariate analysis, age, cytogenetic risk groups, use of ATG and interval from diagnosis to alloSCT were not significant prognostic factors for survival. In all, these results suggest that in AML patients in Rel 1 undergoing myeloablative alloSCT, Bu/Cy and TBI/Cy conditioning regimens can...
Fig:1 Conclusion: In conclusion, the study suggests that the Flu/Bu/Cy/ATG conditioning regimen resulted in better overall survival [OS] and thalassemia GVHD free survival [TGFS] compared to Flu/Thio/Treo regimen in a high-risk transfusion dependent thalassemia [TDT] patients undergoing allo-...
Outcomes After Addition Of Rabbit-ATG To The Standard BU + CY Preparative Regimen For Allogeneic Matched Sibling Donor (MSD) Hematopoietic Stem Cell Transplantation (HSCT) For Hemoglobinopathies In Childrendoi:10.1016/j.bbmt.2009.12.265.